| Drug Type Biosimilar, Colony-stimulating factors | 
| Synonyms Recombinant Human Granulocyte-Macrophage Colony Stimulating Factou, 莫格司亭生物类似药(中国医学科学院医学生物学研究所), 吉洛因 | 
| Target | 
| Action stimulants | 
| Mechanism CSF-2R stimulants(Granulocyte-macrophage colony-stimulating factor receptor stimulants) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date China (01 Jan 2001),  | 
| Regulation- | 

| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Leukopenia | China  | 01 Jan 2001 | |
| Myelodysplastic Syndromes | China  | 01 Jan 2001 | 






